AI CAPITAL INTELLIGENCE

BigHat Biosciences · Series C · USD 75,000,000 · 2026-09-24

Financing facts, at a glance

BigHat Biosciences: financing disclosed on 2026-09-24, Series C, USD 75,000,000. Named investors: DFJ Growth, Premji Invest, Catalio Capital Management, LG Technology Ventures, Sigmas Group, 8VC, Alexandria Venture Investments, Amgen Ventures, Andreessen Horowitz (a16z), Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly and Company, Merck Global Health Innovation Fund, Quadrille Capital, Section 32. This is the amount disclosed for the financing, not a company valuation or an individual investor commitment.

Original source 1 · Original source 2

BigHat Biosciences is recorded in the Industry AI / Drug discovery & life sciences segment. The disclosed financing is Series C, with an amount of USD 75,000,000. Named investors include DFJ Growth, Premji Invest, Catalio Capital Management, LG Technology Ventures, Sigmas Group, 8VC, Alexandria Venture Investments, Amgen Ventures, Andreessen Horowitz (a16z), Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly and Company, Merck Global Health Innovation Fund, Quadrille Capital, Section 32.

Disclosed company name: BigHat Biosciences
Disclosure date: 2026-09-24
Round: Series C
Financing amount: USD 75,000,000
Market coverage: Outside China
Sector: Industry AI / Drug discovery & life sciences
Product form: Enterprise software

Disclosed investors

DFJ Growth, Premji Invest, Catalio Capital Management, LG Technology Ventures, Sigmas Group, 8VC, Alexandria Venture Investments, Amgen Ventures, Andreessen Horowitz (a16z), Discovery Ventures, GRIDS Capital, Intermountain Ventures, Eli Lilly and Company, Merck Global Health Innovation Fund, Quadrille Capital, Section 32

Original sources

Record reviewed as of 2026-10-02. Reported ranges and lower bounds are retained. Financing proceeds are not company valuation.

Company funding history

Explore this sector

DFJ Growth (Chinese)

Premji Invest (Chinese)

Catalio Capital Management (Chinese)

LG Technology Ventures (Chinese)

Sigmas Group (Chinese)

8VC (Chinese)

Alexandria Venture Investments (Chinese)

Amgen Ventures (Chinese)

Andreessen Horowitz (a16z) (Chinese)

Discovery Ventures (Chinese)

GRIDS Capital (Chinese)

Intermountain Ventures (Chinese)

Eli Lilly and Company (Chinese)

Merck Global Health Innovation Fund (Chinese)

Quadrille Capital (Chinese)

Section 32 (Chinese)

All funding records